MENU
YARW Yarrow Bioscience Inc Forecast, Technical & Fundamental Analysis
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases... Show more
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published Earnings
YARW is expected to report earnings to rise 694.39% to -1700 cents per share on November 05
Q3'26
Est.
$-17.00
Q2'26
Missed
by $1.92
The last earnings report on August 13 showed earnings per share of -214 cents, missing the estimate of -21 cents. With 763.00 shares outstanding, the current market capitalization sits at 106.06M.
A.I. Advisor
published General Information